Scalable, High-Density Expansion of Human Mesenchymal Stem Cells on Microcarriers Using the Bach Impeller in Stirred-Tank Reactors
- PMID: 40678872
- DOI: 10.1002/bit.70025
Scalable, High-Density Expansion of Human Mesenchymal Stem Cells on Microcarriers Using the Bach Impeller in Stirred-Tank Reactors
Abstract
This paper describes the results of process developmental experiments to achieve higher cell densities in the manufacturing of hMSCs using the novel Bach impeller in a stirred-tank bioreactor. Engineering experiments have previously shown that the Bach impeller represents an efficient mixing device that suspends particles in fluids at low power inputs. To assess the impeller during biological experiments, the growth performance of Wharton Jelly (WJ)-hMSCs in a 1 L STR equipped with the Bach impeller was evaluated at a variety of culture conditions. The cells attached to Cytodex 1 microcarriers at a concentration of 5.6 g/L and were cultured for 5-7 days. The growth phase was carried out at varying impeller speeds = 75, 115, and 150 rpm. Cell growth was additionally evaluated at a microcarrier concentration of 11.2 g/L Cytodex 1. Here, a maximum cell density of up to 1.7 × 106 cells/mL and cell viability > 90% was achieved within 5 culture days, which is amongst the highest cell densities ever attained for a hMSC batch culture. Critical cell quality attributes of the WJ-hMSCs were assessed upon completion of the growth phase, that is, FACS to identify stem cell surface markers, tri-lineage differentiation, and capacity of the cells to form colonies. In addition, informed by the previously described engineering characterization, the 1 L process at = 75 rpm was scaled up to the 5 L scale, where WJ-hMSCs were again confirmed to have retained the relevant cell quality attributes. The reported findings are important to determine the design space to which scale-ups to even larger tank sizes can adhere.
Keywords: bioprocessing; engineering characterization; mesenchymal stem cells; microcarriers; stirred‐tank reactors.
© 2025 The Author(s). Biotechnology and Bioengineering published by Wiley Periodicals LLC.
Similar articles
-
Cell retention in scalable, perfusion-based mesenchymal stem cell expansion processes: a proof of concept.Front Bioeng Biotechnol. 2025 Jul 4;13:1611703. doi: 10.3389/fbioe.2025.1611703. eCollection 2025. Front Bioeng Biotechnol. 2025. PMID: 40688478 Free PMC article.
-
A GMP-compliant manufacturing method for Wharton's jelly-derived mesenchymal stromal cells.Stem Cell Res Ther. 2024 May 3;15(1):131. doi: 10.1186/s13287-024-03725-0. Stem Cell Res Ther. 2024. PMID: 38702793 Free PMC article.
-
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21. Clin Orthop Relat Res. 2025. PMID: 38905450
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280. Health Technol Assess. 2008. PMID: 18547499
References
-
- Alici, E., and P. Blomberg. 2010. “GMP Facilities for Manufacturing of Advanced Therapy Medicinal Products for Clinical Trials: An Overview for Clinical Researchers.” Current Gene Therapy 10, no. 6: 508–515.
-
- Cantarero‐Rivera, F., D. H. D'Souza, M. Dhar, and J. Chen. 2024. “Characterization of the Dynamic Viscosity of Cell Cultures and Its Effect on Mixing Performance in a Spinner Flask Bioreactor.” Biochemical Engineering Journal 212: 109523.
-
- Charalambidou, A. D., T. A. Wyrobnik, M. Micheletti, and A. Ducci. 2024. “Investigation of the Impact of Probes and Internals on Power and Flow in Stirred Tank Reactors.” Chemical Engineering Science 286: 119683.
-
- Cheatham, L. A., P. Noldner, B. Ressler, and J. Kurtzberg. 2019. “Optimization of Human Umbilical Cord‐Derived Mesenchymal Stem Cell Growth and Expansion Using a Closed‐System Hollow Fiber Bioreactor.” Stem Cells Translational Medicine 8, no. S1: S16.
-
- Chen, A. K. L., S. Reuveny, and S. K. W. Oh. 2013. “Application of Human Mesenchymal and Pluripotent Stem Cell Microcarrier Cultures in Cellular Therapy: Achievements and Future Direction.” Biotechnology Advances 31, no. 7: 1032–1046.
LinkOut - more resources
Full Text Sources
Miscellaneous